REQUEST A DEMO
Total
USD $0.00
Search more companies

Seven Bridges Genomics D.O.O. (Serbia)

Main Activities: Computer Systems Design and Related Services
Full name: Seven Bridges Genomics D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Seven Bridges Genomics D.O.O. is a company based in Serbia, with its head office in Belgrade. The company operates in the Computer Systems Design and Related Services sector. The company was established on January 27, 2011. It currently has a total number of 202 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 16.66% in 2023. During that time, Seven Bridges Genomics D.O.O.’s total assets grew by 35.55%. The net profit margin of Seven Bridges Genomics D.O.O. decreased by 3.88% in 2023.

Headquarters
Omladinskih Brigada 90 G
Belgrade; Belgrade;

Contact Details: Purchase the Seven Bridges Genomics D.O.O. report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Seven Bridges Genomics D.O.O. report to view the information.
Outstanding Shares:
Purchase the Seven Bridges Genomics D.O.O. report to view the information.
Registered Capital:
Purchase the Seven Bridges Genomics D.O.O. report to view the information.
Incorporation Date:
January 27, 2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Seven Bridges Genomics D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-16.66%
Total operating revenue
-17.84%
Operating profit (EBIT)
-27.07%
EBITDA
-16.12%
Net Profit (Loss) for the Period
-49.03%
Total assets
35.55%
Total equity
13.96%
Operating Profit Margin (ROS)
-1.3%
Net Profit Margin
-3.88%
Return on Equity (ROE)
-15.13%
Debt to Equity Ratio
31.2%
Quick Ratio
5.38%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?